Search Results - "HOMESLEY, H. D"

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study by Rose, P G, Blessing, J A, Mayer, A R, Homesley, H D

“…A phase II trial was conducted to determine the activity of prolonged oral etoposide in platinum-resistant and platinum-sensitive ovarian carcinoma…”
Get more information

Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group by THIGPEN, J. T, BRADY, M. F, ALVAREZ, R. D, ADELSON, M. D, HOMESLEY, H. D, MANETTA, A, SOPER, J. T, GIVEN, F. T

“…Progestins have definite activity against advanced or recurrent endometrial carcinoma. Both parenteral and oral progestins yield similar serum levels and…”
Get full text

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study by McGuire, W P, Hoskins, W J, Brady, M F, Homesley, H D, Creasman, W T, Berman, M L, Ball, H, Berek, J S, Woodward, J

“…We report a prospective randomized trial in women with advanced ovarian cancer to evaluate the importance of chemotherapy dose-intensity on survival,…”
Get more information

Tamoxifen in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study by THIGPEN, Tate, BRADY, Mark F, HOMESLEY, Howard D, SOPER, John T, BELL, Jeffrey

“…In two large Gynecologic Oncology Group studies of patients with advanced or recurrent endometrial carcinoma and no previous systemic therapy, progestins have…”
Get full text

Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study by Homesley, Howard D., Bundy, Brian N., Hurteau, Jean A., Roth, Lawrence M.

“…Objectives.The objectives of this study were to assess efficacy and toxicity of the combination of bleomycin, etoposide, and cisplatin (BEP) in this Phase II…”
Get full text

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience by Omura, G A, Brady, M F, Homesley, H D, Yordan, E, Major, F J, Buchsbaum, H J, Park, R C

“…Long-term follow-up was obtained on 726 women with advanced ovarian carcinoma (suboptimal stage III and stage IV) who had received primary chemotherapy on two…”
Get more information

Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study by Homesley, H D, Boike, G, Spiegel, G W

“…To assess laparoscopic management of presumed stage I endometrial cancer, and to compare gross, frozen, and paraffin section methods measuring myoinvasion…”
Get more information

Management of endometrial cancer by Homesley, Howard D.

“…Preoperative assessment requires only endometrial sampling for diagnosis. Curettage is needed when endometrial sampling is unsatisfactory. Transvaginal…”
Get full text

Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study by Creasman, W T, Zaino, R J, Major, F J, DiSaia, P J, Hatch, K D, Homesley, H D

“…Our purpose was to evaluate the risk factors and prognosis in patients with stage IA squamous cell carcinoma of the cervix and 3 to 5 mm of invasion. From 1981…”
Get full text

Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group by Williams, S D, Blessing, J A, Hatch, K D, Homesley, H D

“…Between 1984 and 1989, 20 assessable patients with incompletely resected ovarian dysgerminoma were treated on two protocols of the Gynecologic Oncology Group…”
Get more information

An Analysis of Cell Type in Patients with Surgically Staged Stage IB Carcinoma of the Cervix: A Gynecologic Oncology Group Study by Look, Katherine Y., Brunetto, Virginia L., Clarke-Pearson, Daniel L., Averette, Hervy E., Major, Francis J., Alvarez, Ronald D., Homesley, Howard D., Zaino, Richard J.

“…The influence of cell type on recurrence-free interval (RFI) and survival after radical hysterectomy for patients with Stage IB carcinoma of the cervix was…”
Get full text

Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer: Results of Two Prospective Randomized Trials by Young, Robert C, Walton, Leslie A, Ellenberg, Susan S, Homesley, Howard D, Wilbanks, George D, Decker, David G, Miller, Alexander, Park, Robert, Major, Francis

“…About a third of patients with ovarian cancer present with localized disease; despite surgical resection, up to half the tumors recur. Since it has not been…”
Get full text

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer by Burger, Robert A., DiSaia, Philip J., Roberts, James A., O'Rourke, Mark, Gershenson, David M., Homesley, Howard D., Lichtman, Stuart M., Barnes, Willard, Moore, David H., Monk, Bradley J.

“…Objective.A phase II, multicenter trial was conducted to define the efficacy and safety of vinorelbine (Navelbine (vinorelbine tartrate) injection, NVB) in the…”
Get full text

Management of vulvar cancer by Homesley, H D

“…Current therapy of vulvar malignancies is reviewed with emphasis on screening, etiology, diagnosis, staging, and treatment of preinvasive and invasive cancer…”
Get more information

Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities by Gandara, D R, Nahhas, W A, Adelson, M D, Lichtman, S M, Podczaski, E S, Yanovich, S, Homesley, H D, Braly, P, Ritch, P S, Weisberg, S R

“…Diethyldithiocarbamate (DDTC) blocks cisplatin-induced toxicities in animal models without inhibiting antitumor effects. DDTC chemoprotection was tested in a…”
Get more information

Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study by Sutton, G P, Blessing, J A, Homesley, H D, Berman, M L, Malfetano, J

“…Ifosfamide (isophosphamide) and mesna (2-mercaptoethane sodium sulfonate) were administered intravenously at monthly intervals to 46 patients with advanced…”
Get more information

Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes by Homesley, H D, Bundy, B N, Sedlis, A, Adcock, L

“…From 1977 to 1984, 114 eligible patients with invasive squamous cell carcinoma of the vulva and positive groin nodes after radical vulvectomy and bilateral…”
Get more information

Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma by Homesley, H D, Kadar, N, Barrett, R J, Lentz, S S

“…The objective of this study was to retrospectively assess whether there was increased morbidity associated with the addition of selective pelvic and periaortic…”
Get more information

Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy by Kadar, N, Malfetano, J H, Homesley, H D

“…To determine the factors that influence the survival of patients with endometrial carcinoma histologically confined to the uterus. Retrospective analysis was…”
Get more information

Endometrial cancer: prognostic factors by Homesley, H D, Zaino, R

Get more information